AU2080695A - Pharmaceutical inhalation compositions containing a solid active ingredient - Google Patents

Pharmaceutical inhalation compositions containing a solid active ingredient

Info

Publication number
AU2080695A
AU2080695A AU20806/95A AU2080695A AU2080695A AU 2080695 A AU2080695 A AU 2080695A AU 20806/95 A AU20806/95 A AU 20806/95A AU 2080695 A AU2080695 A AU 2080695A AU 2080695 A AU2080695 A AU 2080695A
Authority
AU
Australia
Prior art keywords
active ingredient
compositions containing
solid active
inhalation compositions
pharmaceutical inhalation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20806/95A
Inventor
Peter John Cole
Peter John Wills
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Heart and Lung Institute
Original Assignee
National Heart and Lung Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Heart and Lung Institute filed Critical National Heart and Lung Institute
Publication of AU2080695A publication Critical patent/AU2080695A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/02—Ammonia; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
AU20806/95A 1994-04-22 1995-03-30 Pharmaceutical inhalation compositions containing a solid active ingredient Abandoned AU2080695A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9408053 1994-04-22
GB9408053A GB9408053D0 (en) 1994-04-22 1994-04-22 Pharmaceutical preparation
PCT/GB1995/000743 WO1995028944A1 (en) 1994-04-22 1995-03-30 Pharmaceutical inhalation compositions containing a solid active ingredient

Publications (1)

Publication Number Publication Date
AU2080695A true AU2080695A (en) 1995-11-16

Family

ID=10753989

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20806/95A Abandoned AU2080695A (en) 1994-04-22 1995-03-30 Pharmaceutical inhalation compositions containing a solid active ingredient

Country Status (4)

Country Link
EP (1) EP0756486A1 (en)
AU (1) AU2080695A (en)
GB (1) GB9408053D0 (en)
WO (1) WO1995028944A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM411494A0 (en) * 1994-02-25 1994-03-24 Central Sydney Area Health Service Method and device for the provocation of upper or lower airway narrowing and/or the induction of sputum
US5747002A (en) * 1995-04-05 1998-05-05 Genentech, Inc. Preparation of sodium chloride aerosol formulations
US6339075B1 (en) 1997-06-30 2002-01-15 The University Of British Columbia Use of dextran and other polysaccharides to improve mucus clearance
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
AU2001241636A1 (en) * 2000-02-23 2001-09-03 The Procter And Gamble Company Halotherapy method
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
ATE508735T1 (en) 2001-12-19 2011-05-15 Novartis Ag PULMONARY ADMINISTRATION OF AMINOGLYCOSIDES
US20090169646A1 (en) * 2006-02-22 2009-07-02 Puricore, Inc. Methods of treating cystic fibrosis
MD4039C1 (en) * 2009-11-05 2010-12-31 Институт Химии Академии Наук Молдовы Surface artificial microsalt mine
MD4089C1 (en) * 2009-11-18 2011-08-31 Институт Химии Академии Наук Молдовы Artificial surface halochamber
MD4040C1 (en) * 2009-12-09 2010-12-31 Институт Химии Академии Наук Молдовы Surface artificial halochamber

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4140689B4 (en) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalable powders and process for their preparation
GB9208584D0 (en) * 1992-04-21 1992-06-03 Albasri Samir A I Effective & safe treatment to nausea and vomiting

Also Published As

Publication number Publication date
EP0756486A1 (en) 1997-02-05
WO1995028944A1 (en) 1995-11-02
GB9408053D0 (en) 1994-06-15

Similar Documents

Publication Publication Date Title
EP0727217A3 (en) Pharmaceutical composition containing god-type ellagitannin as active ingredient
AU1218892A (en) Pharmaceutical aerosol formulations
IL116460A0 (en) Aerosol drug formulations
AU5402296A (en) Pharmaceutical composition for transdermic administration
HUT77377A (en) Pharmaceutical aerosol compositions
AU7547196A (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
AU5945396A (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
AU4595689A (en) Medicinal aerosol formulations
AU7905194A (en) A medicinal aerosol formulation
AU7305594A (en) Physiologically active substance-prolonged releasing-type pharmaceutical preparation
AU7375598A (en) Stable oral pharmaceutical dosage forms
IL115039A (en) Spiroazabicyclic compounds, their preparation and pharmaceutical compositions containing them
AU5177993A (en) Pharmaceutical compositions containing a calcitonin
AU2638297A (en) Oral pharmaceutical preparation containing ibandronat
GB9612297D0 (en) Medicinal aerosol formulations
HUP9901684A3 (en) Lipoprotein (a) lowering activity aminophosphonate derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds
AU3716193A (en) Pharmaceutical compositions
ZA978303B (en) Medicinal aerosol formulations
HU9802795D0 (en) Pharmaceutical compositions containing more active components
IL117050A0 (en) Solid active ingredient compositions containing hydroxypropylcellulose
AU3453897A (en) Medicinal cyclosporin-a aerosol solution formulation
AU2080695A (en) Pharmaceutical inhalation compositions containing a solid active ingredient
AU1252592A (en) Swallowable pharmaceutical compositions
EP0586812A3 (en) Medicaments comprising glicentin as active ingredient.
IL112897A0 (en) Aerosol drug formulations containing vitamin e